Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Spermine Metabolism and Anticancer Therapy

Volume:9   Issue: 2
Pp: 118-130
R. Amendola, M. Cervelli, E. Fratini, F. Polticelli, D. E. Sallustio and P. Mariottini
DOI: 10.2174/156800909787580935

Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer

Volume:9   Issue: 2
Pp: 148-162
Philippe L. Bedard, Evandro de Azambuja and Fatima Cardoso
DOI: 10.2174/156800909787581024

Role of the Akt Pathway in Prostate Cancer

Volume:9   Issue: 2
Pp: 163-175
Paul L. de Souza, Pamela J. Russell and John Kearsley
DOI: 10.2174/156800909787581006

Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System

Volume:9   Issue: 2
Pp: 176-188
Michael A. Grotzer, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby and Alexandre Arcaro
DOI: 10.2174/156800909787580962

Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis

Volume:9   Issue: 2
Pp: 189-201
Xuefei Cao, Carmen Plasencia, Atsuko Kanzaki, Austin Yang, Terrence R. Burke Jr. and Nouri Neamati
DOI: 10.2174/156800909787580971

Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells

Volume:9   Issue: 2
Pp: 202-213
R. Pignatello, D. Paolino, V. Panto, V. Pistara, M. G. Calvagno, D. Russo, G. Puglisi and M. Fresta
DOI: 10.2174/156800909787580944

Nitric Oxide: Cancer Target or Anticancer Agent?

Volume:9   Issue: 2
Pp: 214-236
Simone Mocellin
DOI: 10.2174/156800909787581015

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Volume:9   Issue: 2
Pp: 237-249
Todd M. Morgan, Theodore D. Koreckij and Eva Corey
DOI: 10.2174/156800909787580999